Published in Rev Mal Respir on December 01, 2006
Coral reefs under rapid climate change and ocean acidification. Science (2007) 26.35
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet (2001) 6.88
The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med (1994) 4.87
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J (2010) 2.90
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med (1995) 2.76
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J (2009) 2.41
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J (1998) 2.14
Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax (2005) 2.03
Primary pulmonary hypertension and fenfluramine use. Br Heart J (1993) 2.02
Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients. Cardiovasc Intervent Radiol (2003) 1.96
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J (2009) 1.85
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J (2009) 1.85
HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J Immunol (2000) 1.82
[Guidelines for the diagnosis and treatment of pulmonary hypertension]. Rev Mal Respir (2010) 1.74
Chronic thromboembolic pulmonary hypertension. Eur Respir J (2004) 1.74
Anterior speech region. Asymmetry and weight-surface correlation. Arch Neurol (1989) 1.61
Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Neuroepidemiology (2009) 1.53
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J (2007) 1.51
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med (1995) 1.46
Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood. Blood (1998) 1.46
[Liver capsule retraction adjacent to a circumscribed liver lesion: review of 26 cases with histological confirmation]. J Radiol (2009) 1.44
Pulmonary vascular disorders in portal hypertension. Eur Respir J (1998) 1.44
5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol (2000) 1.42
Web sites help oncology nurses to strengthen leadership positions, easily access resources. ONS News (1998) 1.41
Asymmetric lateral mobility of phospholipids in the human erythrocyte membrane. Proc Natl Acad Sci U S A (1986) 1.41
Management of paroxysmal atrioventricular nodal reentrant tachycardia in the critically ill surgical patient. Crit Care Med (1997) 1.40
[Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan]. Rev Mal Respir (2012) 1.39
Child abdominal tumour in tropical context: think about schistosomiasis! Afr J Paediatr Surg (2014) 1.39
Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis. Br J Haematol (1998) 1.38
Pulmonary veno-occlusive disease. Eur Respir J (2009) 1.37
Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo. EMBO J (2001) 1.35
Pentamidine and pancreatitis. Ann Intern Med (1986) 1.34
Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis (1985) 1.32
Long term imatinib treatment in pulmonary arterial hypertension. Thorax (2006) 1.32
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J (2002) 1.31
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax (2005) 1.29
Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Respir Dis (1986) 1.26
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation (1994) 1.24
Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med (2000) 1.23
Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest (1998) 1.22
Risk factors for pulmonary arterial hypertension. Clin Chest Med (2001) 1.20
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol (2007) 1.14
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J (2011) 1.13
[Impact of computed tomography on patient's care in nontraumatic acute abdomen: 90 patients]. J Radiol (2007) 1.12
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. Eur Respir J (2006) 1.11
Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med (2001) 1.11
Uptake and effects of five heavy metals on seed germination and plant growth in alfalfa (Medicago sativa L.). Bull Environ Contam Toxicol (2001) 1.09
Do the treasures of 'big data' combined with behavioural intervention therapies contain the key to the mystery of large psychiatric issues? Acta Psychiatr Scand (2014) 1.09
Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry (2012) 1.08
Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J (2009) 1.08
Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax (1999) 1.08
Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest (1998) 1.08
Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation (1996) 1.07
Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant (1996) 1.05
A colorimetric assay for rapid screening of antimicrobial peptides. Nat Biotechnol (2000) 1.03
Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. J Exp Clin Cancer Res (2007) 1.03
Preoperative uterine artery embolization (PUAE) before uterine fibroid myomectomy. Cardiovasc Intervent Radiol (2008) 1.02
Human Leydig cells and Sertoli cells are producers of interleukins-1 and -6. J Clin Endocrinol Metab (1997) 1.01
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension. Eur Respir Rev (2009) 1.00
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med (2000) 1.00
Analysis of sperm movement in relation to the oxidative stress created by leukocytes in washed sperm preparations and seminal plasma. Hum Reprod (1995) 1.00
Lung reperfusion injury after chronic or acute unilateral pulmonary artery occlusion. Am J Respir Crit Care Med (1998) 0.99
Closure versus non-closure of hernia defect during laparoscopic ventral hernia repair with mesh. Hernia (2013) 0.99
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J (2008) 0.98
Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy (2009) 0.98
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation (2001) 0.98
Effect of mixed cadmium, copper, nickel and zinc at different pHs upon alfalfa growth and heavy metal uptake. Environ Pollut (2002) 0.98
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis. Am J Physiol Gastrointest Liver Physiol (2009) 0.98
Morphological integrity of the bronchial epithelium in mild asthma. Thorax (1990) 0.98
Hypersplenism due to portal hypertension: retrospective evaluation of 17 patients treated by splenic embolization. Diagn Interv Imaging (2011) 0.96
Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch. Nephrol Dial Transplant (1998) 0.96
Normal diameter of the thoracic aorta in adults: a magnetic resonance imaging study. Surg Radiol Anat (2003) 0.96
Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor. J Rheumatol (1998) 0.95
[Mesenteric panniculitis]. Rev Med Interne (2012) 0.95
A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl) (1979) 0.95
Selenomethionine-substituted Thermus thermophilus cytochrome ba3: characterization of the CuA site by Se and Cu K-EXAFS. Biochemistry (1999) 0.95
Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases. Respiration (2007) 0.94
Combined idiopathic retroperitoneal and mediastinal fibrosis with pericardial involvement. Clin Nephrol (1999) 0.93
Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood (1990) 0.93
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst (1997) 0.93
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. Eur Respir J (2009) 0.92
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension. Circulation (2000) 0.91
[Preventive and emergency embolization of angiomyolipomas: our experience]. Prog Urol (2011) 0.91
Reactive oxygen species generation by human spermatozoa is induced by exogenous NADPH and inhibited by the flavoprotein inhibitors diphenylene iodonium and quinacrine. Mol Reprod Dev (1997) 0.91
Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem J (2000) 0.90
Spinor dynamics in an antiferromagnetic spin-1 condensate. Phys Rev Lett (2007) 0.90
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J (2002) 0.90
A prospective study of 50 cases of familial Parkinson's disease. Can J Neurol Sci (1983) 0.89
[Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med (2005) 0.89
Swallowing in degenerative ataxias. J Neurol (2006) 0.89
Uptake and elimination of radiocaesium in fish and the "size effect.". J Environ Radioact (2002) 0.88
The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment. Stem Cells (1997) 0.88
A biomechanical analysis of articular cartilage of the human elbow and a potential relationship to osteochondritis dissecans. Clin Orthop Relat Res (1994) 0.88
Autologous bone marrow transplantation for acute leukaemia in remission. Br J Haematol (1986) 0.88
Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transplant Proc (2005) 0.88